Gill Gough Therapy

M.E – Myalgic Encephalomyelitis

M.E stands for Myalgic Encephalomyelitis or perhaps more correctly Myalgic Encephalomyelopathy. Mickel Therapy believes that M.E, CFS and Fibromyalgia are all caused by a dysfunction of the Hypothalamus that Dr Mickel has dubbed ‘Hypothalamitis’. This is a broad spectrum of illness with many shared symptoms and degrees of severity. Please note this is a hypothesis only and not backed by scientific research as yet. Similarly the results have not yet been independently studied and are based on client testimony only until the trial of Mickel Therapy is complete and published.

The term M.E is not universally recognised or used worldwide and most areas now refer to cases as having Chronic Fatigue Syndrome. M.E as a term is partly correct. The ‘Mylagic’ purely means painful muscles and as most sufferers of M.E will know this can be extreme. The ‘encephalomyelitis’ however suggests inflammation of the brain and studies fail to prove this in M.E cases and it is really a misnomer.

Much research goes into M.E. This involves looking for viral clues or other infective causes. Some of the most commonly suggested causes are that M.E is due to an unknown virus, Borrelia or Lyme’s Disease, Epstein Barr infection (Glandular Fever), adrenal ‘burnout’ or Candida. Mickel Therapy has consistently treated successfully many cases of M.E who were given the above as causes. This suggests that they are incorrect and further study of such pathogens is a waste of resources. Please note that Mickel Therapy's results are based on client testimony and have not yet been backed up by research. The latter is in place and results will be disseminated when the study is complete.

Through his experiences in treating M.E over the last 10 years Dr Mickel believes strongly that the causes suggested above are inaccurate and if they do exist then they are inconsequential effects of the state of dysfunction in the Hypothalamus (‘Hypothalamitis’). The latter being his hypothesis and is not yet backed by scientific research. The fact that the clients (with cases of M.E) claim that Mickel Therapy has treated them successfully and did not involve any attention to these suggested problems, even if tests showed they had been present, suggests that the case for them being causes must be in doubt. Mickel Therapy is hopeful to prove this point once and for all through the planned Clinical Trials into its work on M.E, Chronic Fatigue Syndrome and Fibromyalgia.

Chronic Fatigue Syndrome

As detailed in Dr Mickel’s book this diagnosis is reached by exclusion of other conditions as directed by the Chief Medical Officer’s Working Group Report 2002.

Chronic Fatigue Syndrome (CFS) is really an unhelpful diagnostic term as it merely describes the symptoms that sufferers know too well. This is a direct result of the failure of Medicine to isolate the cause of the illness. Enormous resources are being spent on researching Chronic Fatigue Syndrome (CFS) but unfortunately much of this directed at the extensive study of the effects of the underlying cause and will not result in reduction in suffering. For example large amounts of time and money are spent looking at the minute detail of the muscles’ metabolic changes present in Chronic Fatigue Syndrome (CFS). This will herald no further information on the actual cause or aid in finding a treatment. Mickel Therapy is confident that the cause lies within the Hypothalamus Gland (dubbed by Dr Mickel as ‘Hypothalamitis’). Please note that while scientific research is starting to point towards the Hypothalamus, the latter is only Dr Mickel's hypothesis - it is not validated by research.  Mickel Therapy is designed to correct this dysfunction and return the Chronic Fatigue Syndrome (CFS) sufferer to full health.

Chronic Fatigue Syndrome (CFS) is reaching epidemic in proportions in the world at large and Mickel Therapy is confident that it has the means to correct this. Convincing the medical world of this has never been easy but Dr Mickel hopes that the result of his Randomised Controlled Clinical Trial will solve this and make the treatment available to all Chronic Fatigue Syndrome sufferers. 2005